Not applicableStudy completedNCT02733445
What this trial is testing
Metabolic Outcomes in Patients Receiving Tyrosine Kinase Inhibitor (TKI) Therapy With Dasatinib or Nilotinib
Who this might be right for
Chronic Myeloid Leukemia (CML)
Bristol-Myers Squibb 2,650